GENTA INCORPORATED /DE/
4, 1998-01-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 4, 1998-01-12
Next: GENTA INCORPORATED /DE/, 4, 1998-01-12



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Weiss, Michael S.
   787 Seventh Avenue, 48th Floor
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   Genta Incorporated /DE/
   GNTA
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   12/29/97
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   (X) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   ( ) Form filed by One Reporting Person
   (X) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Series D Convertible P|$0.94375|12/29|J(2)| |5,934      |A  |12/31|N/A  |Common Stock|628,768|(2)    |6,017(3)    |5,9|            |
referred Stock(1)     |        |/97  |    | |           |   |/97  |     |            |       |       |            |34I|            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants(1)   |$0.94375|12/29|J(2)| |29,670     |A  |12/31|6/30/|Common Stock|29,670 |(2)    |30,420(3)   |29,|            |
                      |        |/97  |    | |           |   |/97  |97   |            |       |       |            |670|            |
                      |        |     |    | |           |   |     |     |            |       |       |            |I   |           |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1)  The Series D Preferred  Stock and Class D Warrants are  components of units
     ("Units")  issuable upon exercise of warrants  ("Unit  Purchase  Warrants")
     exercisable from December 31, 1997 to June 30, 2002, at an initial exercise
     price of $110,000 per Unit. Michael S. Weiss,  individually and through the
     holdings of Hawkins  Group,  LLC,  may be deemed  beneficially  to own Unit
     Purchase Warrants to purchase 1.18676 and 4.74708 Units, respectively. Each
     Unit consists,  initially,  of (i) 1,000 shares of Series D Preferred Stock
     of the Issuer, par value $0.001 per share, and (ii) 5,000 Class D Warrants.
     The Unit Purchase Warrants contain certain anti-dilution adjustments.
(2)  On December 29, 1997,  Paramount  Capital Inc.  designated  recipients (the
     "Paramount Warrant Designees") of the Unit Purchase Warrants. Mr. Weiss and
     Hawkins Group,  LLC, of which Mr. Weiss is Managing Member,  were among the
     Paramount  Warrant  Designees and received  such Unit Purchase  Warrants in
     connection with a private placement (the "Private Placement") of securities
     of the Issuer of which Paramount  Capital,  Inc. acted as placement  agent.
     (3) Mr. Weiss also owns,  directly,  150 shares of Series D Preferred Stock
     and 750 Class D Warrants, which he purchased in the Private Placement.


SIGNATURE OF REPORTING PERSON
/s/Michael S. Weiss
- ----------------------------------------------------------
Michael S. Weiss
Individually, and as Managing Member of Hawkins Group, LLC
DATE
1/9/98

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed.
        If space provided is insufficient, see Instruction 6 for procedure.
 
Potential persons who are to respond to the collection of information  contained
in this form are not  required to respond  unless the form  displays a currently
valid OMB Number.


<PAGE>

Attachment A


         Reporting Persons:        Michael S. Weiss (the designated filer); and

                                   Hawkins Group, LLC
                                   787 Seventh Avenue, 48th Floor
                                   New York, NY  10019

         Issuer:                   Genta Incorporated (GNTA)

         Statement For:            December / 1997

         Michael S. Weiss is  Managing  Member of  Hawkins  Group,  LLC and is a
Director of the Issuer.  Each  of the  Reporting  Persons  disclaims  beneficial
ownership  of the  securities  held by the other,  except to the extent of their
pecuniary interest therein, if any.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission